Brain: Tumours

(asked on 19th March 2024) - View Source

Question to the Department of Health and Social Care:

To ask His Majesty's Government, following research from Cancer Research UK which found that brain, other central nervous system and intracranial tumours incidence rates have increased by almost two-fifths in the UK since the early 1990s, what steps they are taking to ensure that the funding spent on brain tumour research keeps pace with the increased incidence.


Answered by
Lord Markham Portrait
Lord Markham
Parliamentary Under-Secretary (Department of Health and Social Care)
This question was answered on 26th March 2024

Research is crucial in tackling cancer, which is why the Department invests over £1 billion per year in health research, through the National Institute for Health Research (NIHR). NIHR research expenditure for all cancers was £121.8 million in 2022/23, and the NIHR spends more on cancer than any other disease group.

The NIHR funds research in response to proposals received from scientists rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.

In May 2018 the Government announced £40 million for brain tumour research as part of the Tessa Jowell Brain Cancer Mission (TJBCM) through the NIHR. Since the 2018 announcement, the NIHR has committed £11.3 million across 17 projects. It is worth noting that all applications that were fundable in open competition, have been funded.

There is still funding available from the original £40 million announced in 2018. We are committed to funding high-quality brain cancer research, and we expect to spend more as new research progresses.

Brain tumours are a difficult research area with a relatively small research community. To increase the quality, diversity, and number of brain cancer research proposals, the NIHR is working with the TJBCM and the research community to develop research capacity in the brain cancer community. The NIHR continues to encourage and welcome more funding applications for research into brain tumours.

Reticulating Splines